awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38210345-B4A89BDC-B005-471D-8572-8C0379BEA96B
Q38210345-B4A89BDC-B005-471D-8572-8C0379BEA96B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38210345-B4A89BDC-B005-471D-8572-8C0379BEA96B
Advances in managing hepatocellular carcinoma.
P2860
Q38210345-B4A89BDC-B005-471D-8572-8C0379BEA96B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38210345-B4A89BDC-B005-471D-8572-8C0379BEA96B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f78f82cc3489bf31e79b2ec6cb701a3371a00be9
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.